Literature DB >> 21327024

Developmental biology of gut-probiotic interaction.

Ravi Mangal Patel1, Patricia W Lin.   

Abstract

While our current knowledge of probiotic interaction in the developing gut remains poorly understood, emerging science is providing greater biological insight into their mechanism of action and therapeutic potential for human disease. Given their beneficial effects, probiotics remain promising agents in neonatal gastrointestinal disorders. Probiotics may restore or supply essential bacterial strains needed for gut maturation and homeostasis, particularly in hosts where this process has been disrupted. Here we highlight the unique characteristics of developing intestinal epithelia with a focus on gut development and colonization as well as the inflammatory propensity of immature epithelia. Additionally, we review potential mechanisms of beneficial probiotic interaction with immature intestinal epithelia including immunomodulation, upregulation of cytoprotective genes, prevention and regulation of apoptosis and maintenance of barrier function. Improved knowledge of gut-probiotic interaction in developing epithelia will allow for a better understanding of how probiotics exert their beneficial effects and help guide their therapeutic use.

Entities:  

Keywords:  commensal bacteria; gut inflammation; intestinal epithelia; necrotizing enterocolitis; ontogeny; probiotics

Mesh:

Year:  2010        PMID: 21327024      PMCID: PMC3023598          DOI: 10.4161/gmic.1.3.12484

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  113 in total

Review 1.  Apoptosis in the intestinal epithelium: its relevance in normal and pathophysiological conditions.

Authors:  A Ramachandran; M Madesh; K A Balasubramanian
Journal:  J Gastroenterol Hepatol       Date:  2000-02       Impact factor: 4.029

2.  Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors:  A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

3.  Intestinal permeability in relation to birth weight and gestational and postnatal age.

Authors:  R M van Elburg; W P F Fetter; C M Bunkers; H S A Heymans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

4.  Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells.

Authors:  Meng-Tsung Tien; Stephen E Girardin; Béatrice Regnault; Lionel Le Bourhis; Marie-Agnès Dillies; Jean-Yves Coppée; Raphaëlle Bourdet-Sicard; Philippe J Sansonetti; Thierry Pédron
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

5.  Lactobacillus sepsis associated with probiotic therapy.

Authors:  Anjali N Kunz; Mary P Fairchok; James M Noel
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

6.  Mucin gene expression in human embryonic and fetal intestine.

Authors:  M P Buisine; L Devisme; T C Savidge; C Gespach; B Gosselin; N Porchet; J P Aubert
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 7.  Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis.

Authors:  M S Caplan
Journal:  J Perinatol       Date:  2009-05       Impact factor: 2.521

8.  The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation.

Authors:  Amrita Kumar; Huixia Wu; Lauren S Collier-Hyams; Young-Man Kwon; Jason M Hanson; Andrew S Neish
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  21 in total

1.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

2.  Developmental expression of IL-12Rβ2 on murine naive neonatal T cells counters the upregulation of IL-13Rα1 on primary Th1 cells and balances immunity in the newborn.

Authors:  Christine M Hoeman; Mermagya Dhakal; Adam A Zaghouani; Jason A Cascio; Xiaoxiao Wan; Marie-Therese Khairallah; Weirong Chen; Habib Zaghouani
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

3.  Effect of Feeding Soy Milk Fermented by Probiotic Bacteria on Some Blood Criteria and Weight of Experimental Animals.

Authors:  Alaa Kareem Niamah; Ali Ahmed Sahi; Alaa S N Al-Sharifi
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

4.  Gut bacteria in health and disease.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

5.  Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses.

Authors:  Brett M Jakaitis; Patricia W Denning
Journal:  Pathophysiology       Date:  2014-01-17

6.  The role of intestinal epithelial barrier function in the development of NEC.

Authors:  Melissa D Halpern; Patricia W Denning
Journal:  Tissue Barriers       Date:  2015-01-22

Review 7.  Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?

Authors:  Ravi Mangal Patel; Patricia Wei Denning
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

8.  Probiotics in addition to antibiotics for the treatment of acute tonsillitis: a randomized, placebo-controlled study.

Authors:  P Gilbey; L Livshits; A Sharabi-Nov; Y Avraham; D Miron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-24       Impact factor: 3.267

9.  Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats.

Authors:  Ying-Jie Sun; Hui-Juan Cao; Dan-Dan Song; Yu-Gang Diao; Jin Zhou; Tie-Zheng Zhang
Journal:  Dig Dis Sci       Date:  2013-01-19       Impact factor: 3.199

Review 10.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.